FMR LLC trimmed its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 3.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,824,958 shares of the health services provider's stock after selling 294,302 shares during the period. FMR LLC owned about 14.66% of Maximus worth $822,133,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Assenagon Asset Management S.A. grew its position in shares of Maximus by 151.6% in the 2nd quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider's stock valued at $19,980,000 after buying an additional 140,481 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of Maximus by 942.9% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider's stock valued at $27,707,000 after purchasing an additional 292,300 shares during the last quarter. Tidal Investments LLC increased its position in shares of Maximus by 238.9% during the first quarter. Tidal Investments LLC now owns 12,763 shares of the health services provider's stock worth $1,071,000 after buying an additional 8,997 shares during the period. SG Americas Securities LLC raised its stake in Maximus by 609.6% during the second quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider's stock worth $1,224,000 after buying an additional 12,266 shares during the last quarter. Finally, Versor Investments LP raised its stake in Maximus by 213.5% during the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider's stock worth $792,000 after buying an additional 5,789 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Maximus Trading Down 0.5 %
Shares of MMS stock traded down $0.39 during mid-day trading on Thursday, hitting $72.50. The company's stock had a trading volume of 1,701,725 shares, compared to its average volume of 408,183. The company has a market cap of $4.37 billion, a PE ratio of 14.50 and a beta of 0.77. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49. The company's fifty day simple moving average is $87.17 and its 200-day simple moving average is $87.75. Maximus, Inc. has a 52 week low of $71.75 and a 52 week high of $93.97.
Maximus Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Saturday, November 30th. Shareholders of record on Friday, November 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.66%. The ex-dividend date of this dividend is Friday, November 15th. Maximus's dividend payout ratio (DPR) is currently 24.00%.
Insider Activity
In other news, insider Michelle F. Link sold 1,363 shares of the company's stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total transaction of $126,159.28. Following the transaction, the insider now directly owns 6,567 shares of the company's stock, valued at $607,841.52. This represents a 17.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.40% of the company's stock.
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Recommended Stories
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.